The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ ... First, a bit of background on Vertex's CF program since it's so central to the company's growth.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $484.01, marking a +0.11% move from the previous day. This change outpaced the S&P 500's 4.84% loss on the day. At the same ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

The COVID-19 crisis is causing a surge in interest in ‘virtual trials’ where the ... director of data management and metrics for Vertex Pharmaceuticals, told the conference that the COVID ...

Vertex Pharmaceuticals generated more than $11 ... Let's find out. First, a bit of background on Vertex's CF program since it's so central to the company's growth. The company dominates this ...